Lifeboat Foundation

There’s a meditative state described in ancient Buddhist scriptures that is hard to imagine because it is not something – but nothing. Referred to as nirodha-samāpatti, it roughly translates as ‘the cessation of thought and feeling’, and it is the highest meditative state possible in Theravada Buddhism, following eight others called jhānas. Each jhāna requires deepening levels of concentration, and a retreat into the mind, away from typical consciousness.

According to David Vago, a psychologist at Vanderbilt University in Nashville and director of the Contemplative Neuroscience and Mind-Body Research Laboratory, nirodha-samāpatti refers to a ‘state of profound concentration or absorption in which all mental activity is temporarily suspended’. It’s said that the state leads to a total absence of sensation and awareness, which would help explain the stories of monks who stayed in this deep trance while fires burned around them.

Continue reading “What happens to the brain during consciousness-ending meditation?” »

Complex spikes (CSs) driven by inferior olivary neurons have crucial roles in motor control. Wang et al. identified an excitatory pathway from the cerebellar nuclei to the inferior olive that drives rapid feedback CSs and contributes to the fine control of ocular and body movements.

For over a hundred years, scientists have held the belief that our thoughts, feelings, and dreams are shaped by the way various brain regions interact via a vast network of trillions of cellular connections.

However, a recent study led by the team at Monash University’s Turner Institute for Brain and Mental Health has examined more than 10,000 distinct maps of human brain activity and discovered that the overall shape of an individual’s brain has a much more substantial impact on our cognitive processes, emotions, and behavior than its intricate neuronal connectivity.

The study, recently published in the prestigious journal, Nature draws together approaches from physics, neuroscience, and psychology to overturn the century-old paradigm emphasizing the importance of complex brain connectivity, instead identifying a previously unappreciated relationship between brain shape and activity.

Summary: This week’s neuroscience revelations encompass intriguing findings from the enigmatic genetics of mind-controlling hairworms to the groundbreaking link between alcohol use disorders and certain neuronal plasticity genes.

A novel theory proposes that the location of memory storage in the brain depends on its generalizability rather than age, adding a new dimension to our understanding of memory management. A new AI system demonstrates an impressive ability to identify violations of social norms, promising advancements in AI capabilities.

Continue reading “Brain Bites: Top 5 Neuroscience News Articles of the Week” »

Traumatic brain injury (TBI) is increasingly a major cause of disability across the globe. The current methods of diagnosis are inadequate at classifying patients and prognosis. TBI is a diagnostic and therapeutic challenge. There is no Food and Drug Administration (FDA)-approved treatment for TBI yet. It took about 16 years of preclinical research to develop accurate and objective diagnostic measures for TBI. Two brain-specific protein biomarkers, namely, ubiquitin C-terminal hydrolase-L1 and glial fibrillary acidic protein, have been extensively characterized. Recently, the two biomarkers were approved by the FDA as the first blood-based biomarker, Brain Trauma Indicator™ (BTI™), via the Breakthrough Devices Program. This scoping review presents (i) TBI diagnosis challenges, (ii) the process behind the FDA approval of biomarkers, and (iii) known unknowns in TBI biomarker biology.

There’s an exciting new development in the field of Alzheimer’s disease research. Surprisingly, it centers around a common bodybuilding supplement known as HMB. The key to preserving memory and staving off this devastating disease may, in fact, reside in the diet of those pumping iron at the gym.

Researchers from RUSH Medical College have recently revealed that the muscle-enhancing supplement known as beta-hydroxy beta-methylbutyrate (HMB) could hold potential in the fight against Alzheimer’s disease.

The supplement, frequently used by bodybuilders to boost muscle growth and enhance performance, might also aid in memory protection, plaque reduction, and slowing the progression of Alzheimer’s disease.

In a way, the brain changes its channels as we go about our day to match our internal state of mind to outside requirements—though at any point, the channels can bleed over.

But there’s a mysterious outcast: a frequency called theta waves. They happen while we’re awake or asleep. For decades, these waves have taunted neuroscientists trying to decipher their functions. Theta waves seem to help mice navigate mazes, but also support memory in humans.

It’s not just academic curiosity. Our ability to navigate complex new environments and keep those memories declines with age. It’s especially tough for people with Alzheimer’s disease. By finding the driving source of theta waves, we could potentially enhance them—using neurostimulation or other methods—to slow cognitive decline.

The visionary CEO says his companies could one day offer hope to amputees by giving them a prosthetic limb that could one day be better than a biological one.

The study also confirmed past research showing that superagers have a greater volume of gray matter associated with memory in parts of the brain.

In an editorial commentary accompanying the study, researchers Dr. Alexandra Touroutoglous, Dr. Bonnie Wong, and Dr. Joseph M Andreano of Harvard Medical School said this finding primarily focused on the medial temporal lobe of the brain, “which is consistent with previous research.”